KAMADA LTD (KMDA) Stock Fundamental Analysis
USA - NASDAQ:KMDA - IL0010941198 - Common Stock
6.82 USD
-0.1 (-1.45%)
We assign a fundamental rating of 6 out of 10 to KMDA. KMDA was compared to 534 industry peers in the Biotechnology industry. While KMDA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. KMDA may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, KMDA could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
In the past year KMDA was profitable.
KMDA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: KMDA reported negative net income in multiple years.
Of the past 5 years KMDA 4 years had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 5.16%, KMDA belongs to the best of the industry, outperforming 91.57% of the companies in the same industry.
With an excellent Return On Equity value of 7.31%, KMDA belongs to the best of the industry, outperforming 92.51% of the companies in the same industry.
KMDA's Return On Invested Capital of 6.18% is amongst the best of the industry. KMDA outperforms 93.26% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for KMDA is significantly below the industry average of 15.49%.
The 3 year average ROIC (2.98%) for KMDA is below the current ROIC(6.18%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.16% | ||
| ROE | 7.31% | ||
| ROIC | 6.18% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of KMDA (11.21%) is better than 92.51% of its industry peers.
KMDA's Profit Margin has declined in the last couple of years.
KMDA has a Operating Margin of 14.89%. This is amongst the best in the industry. KMDA outperforms 93.45% of its industry peers.
In the last couple of years the Operating Margin of KMDA has declined.
Looking at the Gross Margin, with a value of 43.62%, KMDA is in the better half of the industry, outperforming 74.53% of the companies in the same industry.
KMDA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.89% | ||
| PM (TTM) | 11.21% | ||
| GM | 43.62% |
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), KMDA is destroying value.
KMDA has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for KMDA has been increased compared to 5 years ago.
KMDA has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.27 indicates that KMDA is not in any danger for bankruptcy at the moment.
KMDA's Altman-Z score of 3.27 is fine compared to the rest of the industry. KMDA outperforms 70.04% of its industry peers.
The Debt to FCF ratio of KMDA is 0.36, which is an excellent value as it means it would take KMDA, only 0.36 years of fcf income to pay off all of its debts.
KMDA has a better Debt to FCF ratio (0.36) than 95.69% of its industry peers.
KMDA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
KMDA has a Debt to Equity ratio (0.04) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.36 | ||
| Altman-Z | 3.27 |
ROIC/WACC0.71
WACC8.69%
2.3 Liquidity
KMDA has a Current Ratio of 4.00. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
KMDA has a Current ratio (4.00) which is comparable to the rest of the industry.
A Quick Ratio of 2.21 indicates that KMDA has no problem at all paying its short term obligations.
KMDA has a Quick ratio of 2.21. This is in the lower half of the industry: KMDA underperforms 70.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 2.21 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 25.93% over the past year.
KMDA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.60% yearly.
The Revenue has grown by 9.67% in the past year. This is quite good.
KMDA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.82% yearly.
EPS 1Y (TTM)25.93%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%62.5%
Revenue 1Y (TTM)9.67%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%5.37%
3.2 Future
KMDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.77% yearly.
Based on estimates for the next years, KMDA will show a quite strong growth in Revenue. The Revenue will grow by 9.34% on average per year.
EPS Next Y50.06%
EPS Next 2Y28.87%
EPS Next 3Y30.77%
EPS Next 5YN/A
Revenue Next Year12.07%
Revenue Next 2Y11.09%
Revenue Next 3Y9.34%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 20.06, the valuation of KMDA can be described as rather expensive.
Based on the Price/Earnings ratio, KMDA is valued cheaper than 94.94% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.19. KMDA is valued slightly cheaper when compared to this.
KMDA is valuated correctly with a Price/Forward Earnings ratio of 15.79.
Based on the Price/Forward Earnings ratio, KMDA is valued cheaper than 94.38% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of KMDA to the average of the S&P500 Index (22.50), we can say KMDA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.06 | ||
| Fwd PE | 15.79 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KMDA indicates a rather cheap valuation: KMDA is cheaper than 97.19% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of KMDA indicates a rather cheap valuation: KMDA is cheaper than 97.19% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.45 | ||
| EV/EBITDA | 8.63 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KMDA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as KMDA's earnings are expected to grow with 30.77% in the coming years.
PEG (NY)0.4
PEG (5Y)N/A
EPS Next 2Y28.87%
EPS Next 3Y30.77%
5. Dividend
5.1 Amount
KMDA has a Yearly Dividend Yield of 2.91%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 88.05, KMDA pays a better dividend. On top of this KMDA pays more dividend than 98.88% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, KMDA pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.91% |
5.2 History
KMDA is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y28.87%
EPS Next 3Y30.77%
NASDAQ:KMDA (10/30/2025, 8:21:22 PM)
6.82
-0.1 (-1.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners10.9%
Inst Owner Change0%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap393.38M
Revenue(TTM)169.52M
Net Income(TTM)19.01M
Analysts84.44
Price Target16.32 (139.3%)
Short Float %0.12%
Short Ratio0.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.91% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.66%
Min EPS beat(2)1.67%
Max EPS beat(2)45.66%
EPS beat(4)4
Avg EPS beat(4)19.74%
Min EPS beat(4)1.67%
Max EPS beat(4)45.66%
EPS beat(8)7
Avg EPS beat(8)31.91%
EPS beat(12)10
Avg EPS beat(12)19.39%
EPS beat(16)10
Avg EPS beat(16)-93.5%
Revenue beat(2)1
Avg Revenue beat(2)0.35%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)2.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.59%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.79%
Revenue beat(12)4
Avg Revenue beat(12)-0.43%
Revenue beat(16)5
Avg Revenue beat(16)0.29%
PT rev (1m)0%
PT rev (3m)8.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.78%
EPS NY rev (1m)0%
EPS NY rev (3m)16.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.06 | ||
| Fwd PE | 15.79 | ||
| P/S | 2.32 | ||
| P/FCF | 12.45 | ||
| P/OCF | 9.81 | ||
| P/B | 1.51 | ||
| P/tB | 1.71 | ||
| EV/EBITDA | 8.63 |
EPS(TTM)0.34
EY4.99%
EPS(NY)0.43
Fwd EY6.33%
FCF(TTM)0.55
FCFY8.03%
OCF(TTM)0.7
OCFY10.2%
SpS2.94
BVpS4.51
TBVpS3.98
PEG (NY)0.4
PEG (5Y)N/A
Graham Number5.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.16% | ||
| ROE | 7.31% | ||
| ROCE | 7.83% | ||
| ROIC | 6.18% | ||
| ROICexc | 7.78% | ||
| ROICexgc | 8.82% | ||
| OM | 14.89% | ||
| PM (TTM) | 11.21% | ||
| GM | 43.62% | ||
| FCFM | 18.63% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.78%
ROICexc(5y)N/A
ROICexgc(3y)8.93%
ROICexgc(5y)N/A
ROCE(3y)3.78%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-12.12%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.72%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score6
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.36 | ||
| Debt/EBITDA | 0.24 | ||
| Cap/Depr | 58.03% | ||
| Cap/Sales | 5.03% | ||
| Interest Coverage | 35.45 | ||
| Cash Conversion | 100.46% | ||
| Profit Quality | 166.16% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 2.21 | ||
| Altman-Z | 3.27 |
F-Score6
WACC8.69%
ROIC/WACC0.71
Cap/Depr(3y)51.63%
Cap/Depr(5y)66.68%
Cap/Sales(3y)4.57%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.93%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%62.5%
EPS Next Y50.06%
EPS Next 2Y28.87%
EPS Next 3Y30.77%
EPS Next 5YN/A
Revenue 1Y (TTM)9.67%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%5.37%
Revenue Next Year12.07%
Revenue Next 2Y11.09%
Revenue Next 3Y9.34%
Revenue Next 5YN/A
EBIT growth 1Y50%
EBIT growth 3YN/A
EBIT growth 5Y-2.54%
EBIT Next Year134.93%
EBIT Next 3Y35.01%
EBIT Next 5YN/A
FCF growth 1Y387.49%
FCF growth 3YN/A
FCF growth 5Y7.84%
OCF growth 1Y257.57%
OCF growth 3YN/A
OCF growth 5Y11.54%
KAMADA LTD / KMDA FAQ
Can you provide the ChartMill fundamental rating for KAMADA LTD?
ChartMill assigns a fundamental rating of 6 / 10 to KMDA.
Can you provide the valuation status for KAMADA LTD?
ChartMill assigns a valuation rating of 8 / 10 to KAMADA LTD (KMDA). This can be considered as Undervalued.
Can you provide the profitability details for KAMADA LTD?
KAMADA LTD (KMDA) has a profitability rating of 7 / 10.
Can you provide the financial health for KMDA stock?
The financial health rating of KAMADA LTD (KMDA) is 6 / 10.
Can you provide the expected EPS growth for KMDA stock?
The Earnings per Share (EPS) of KAMADA LTD (KMDA) is expected to grow by 50.06% in the next year.